Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

7248-28-4

Strychnine-n-oxide 3H2O

7248-28-4
22189-32-8

Spectinomycin diHClpentahydrate

22189-32-8
6190-55-2

Sulfaguanidine monohydrate

6190-55-2
23256-23-7

Sulfatroxazole

23256-23-7
599-79-1

Sulfasalazine

599-79-1
963-14-4

Sulfaethoxypyridazine

963-14-4
152-47-6

Sulfalene

152-47-6
53003-10-4

Salinomycin

53003-10-4
1126745-90-1

Sildenafil D3

1126745-90-1
28664-35-9

Sotolon

28664-35-9
138-52-3

Salicin

138-52-3
1190307-88-0

Sofosbuvir

1190307-88-0
207737-97-1

Sodium taurodeoxycholate hydrate

207737-97-1
121268-17-5

Sodium alendronate 3H2O

121268-17-5
NA

Spilanthol A mixture of (2E, 6Z, 8E) >80%

NA
1217741-83-7

(±)-cis-Sertraline D3 HCl (N-methyl D3)

1217741-83-7
3366-95-8

Secnidazole

3366-95-8
1405-53-4

Tylosine phosphate

1405-53-4
58-22-0

Testosterone

58-22-0
60-54-8

Tetracycline

60-54-8